QLS12010 / Qilu Pharma - LARVOL DELTA

QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa (clinicaltrials.gov) - P2 | N=102 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P2 trial • Dermatology • Hidradenitis Suppurativa • Immunology

QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis (clinicaltrials.gov) - P2 | N=180 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P2 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology • CRP

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=160 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology